Figures S1–S5 . " width="100%" height="100%">
Journal: Cell Genomics
Article Title: Binding domain mutations provide insight into CTCF’s relationship with chromatin and its contribution to gene regulation
doi: 10.1016/j.xgen.2025.100813
Figure Lengend Snippet: CTCF complementation system (A) Scheme of the CTCF doxycycline-inducible degron system. (B) Experimental strategy for the expression of WT and mutant transgenic CTCF. (C) Flow cytometry showing the level of GFP (endogenous CTCF) and mRuby (transgenic WT CTCF). (D) Left, scheme showing the locations of the different types of CTCF mutations within a ZF. Amino acids making contacts with the DNA are shown in shades of pink, residues that coordinate the zinc ion in red, boundary residues in purple, and residues that contact the sugar phosphate backbone of DNA in blue. Right, representation of CTCF showing the locations of each mutation under investigation. (E) Bar graph showing the expression levels (mean fluorescence intensity) of endogenous CTCF (GFP) and transgenic WT or mutant CTCF (mRuby2) after ID treatment. The error bars represent the standard deviation between the two replicates. (F) Western blot of endogenous CTCF (CTCF antibody) and transgenic CTCF (FLAG antibody) in untreated (WT-U), IAA, ID conditions. See also Figures S1–S5 .
Article Snippet: mouse anti CTCF (Chip-seq) , Cell signaling , Cat#3418, RRID: AB_2086791.
Techniques: Expressing, Mutagenesis, Transgenic Assay, Flow Cytometry, Fluorescence, Standard Deviation, Western Blot